APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade Omega-3

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade Omega-3 Market Outlook and Growth Opportunities 2026

29 December 2025212 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade Omega-3 Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade Omega-3 Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade Omega-3 Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade Omega-3 Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade Omega-3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade Omega-3 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade Omega-3 market include DSM, BASF, Xinzhou, TASA, Solutex, Skuny, Sinomega, Shandong Yuwang Pharmaceutical and Polaris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade Omega-3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade Omega-3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade Omega-3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Omega-3 market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade Omega-3 Segment by Company

DSM

BASF

Xinzhou

TASA

Solutex

Skuny

Sinomega

Shandong Yuwang Pharmaceutical

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

LYSI

Kinomega

KD Pharma (Marine Ingredients)

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

Croda

Bioprocess Algae

Auqi

Anti-Cancer

Pharmaceutical Grade Omega-3 Segment by Type

Marine Omega-3

Algae Omega-3

Pharmaceutical Grade Omega-3 Segment by Application

Pharmaceutical

Cosmetic

Pharmaceutical Grade Omega-3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Grade Omega-3 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade Omega-3 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade Omega-3 significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade Omega-3 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Omega-3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Omega-3 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Omega-3 industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade Omega-3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade Omega-3 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade Omega-3 Industry Trends Table 2. Pharmaceutical Grade Omega-3 Industry Drivers Table 3. Pharmaceutical Grade Omega-3 Industry Opportunities and Challenges Table 4. Pharmaceutical Grade Omega-3 Industry Restraints Table 5. Global Pharmaceutical Grade Omega-3 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade Omega-3 Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade Omega-3 Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade Omega-3 Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Pharmaceutical Grade Omega-3 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade Omega-3 Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade Omega-3 Company, Product Type & Application Table 13. Global Pharmaceutical Grade Omega-3 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade Omega-3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Marine Omega-3 Table 18. Significant Companies of Algae Omega-3 Table 19. Global Pharmaceutical Grade Omega-3 Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Pharmaceutical Grade Omega-3 Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Pharmaceutical Grade Omega-3 Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Type (2021-2026) Table 23. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Type (2027-2032) Table 24. Global Pharmaceutical Grade Omega-3 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Grade Omega-3 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Grade Omega-3 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Grade Omega-3 Sales Value Share by Type (2021-2026) Table 28. Global Pharmaceutical Grade Omega-3 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical Table 30. Significant Companies of Cosmetic Table 31. Global Pharmaceutical Grade Omega-3 Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Pharmaceutical Grade Omega-3 Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Pharmaceutical Grade Omega-3 Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Application (2021-2026) Table 35. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Application (2027-2032) Table 36. Global Pharmaceutical Grade Omega-3 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Grade Omega-3 Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Grade Omega-3 Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Pharmaceutical Grade Omega-3 Sales Value Share by Application (2021-2026) Table 40. Global Pharmaceutical Grade Omega-3 Sales Value Share by Application (2027-2032) Table 41. Global Pharmaceutical Grade Omega-3 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Pharmaceutical Grade Omega-3 Sales by Region (2021-2026) & (Tons) Table 43. Global Pharmaceutical Grade Omega-3 Sales Market Share by Region (2021-2026) Table 44. Global Pharmaceutical Grade Omega-3 Sales by Region (2027-2032) & (Tons) Table 45. Global Pharmaceutical Grade Omega-3 Sales Market Share by Region (2027-2032) Table 46. Global Pharmaceutical Grade Omega-3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pharmaceutical Grade Omega-3 Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Pharmaceutical Grade Omega-3 Sales Value Share by Region (2021-2026) Table 49. Global Pharmaceutical Grade Omega-3 Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Pharmaceutical Grade Omega-3 Sales Value Share by Region (2027-2032) Table 51. Global Pharmaceutical Grade Omega-3 Market Average Price (US$/Kg) by Region (2021-2026) Table 52. Global Pharmaceutical Grade Omega-3 Market Average Price (US$/Kg) by Region (2027-2032) Table 53. Global Pharmaceutical Grade Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Pharmaceutical Grade Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Pharmaceutical Grade Omega-3 Sales by Country (2021-2026) & (Tons) Table 56. Global Pharmaceutical Grade Omega-3 Sales Market Share by Country (2021-2026) Table 57. Global Pharmaceutical Grade Omega-3 Sales by Country (2027-2032) & (Tons) Table 58. Global Pharmaceutical Grade Omega-3 Sales Market Share by Country (2027-2032) Table 59. Global Pharmaceutical Grade Omega-3 Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Pharmaceutical Grade Omega-3 Sales Value Market Share by Country (2021-2026) Table 61. Global Pharmaceutical Grade Omega-3 Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Pharmaceutical Grade Omega-3 Sales Value Market Share by Country (2027-2032) Table 63. DSM Company Information Table 64. DSM Business Overview Table 65. DSM Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. DSM Pharmaceutical Grade Omega-3 Product Portfolio Table 67. DSM Recent Development Table 68. BASF Company Information Table 69. BASF Business Overview Table 70. BASF Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. BASF Pharmaceutical Grade Omega-3 Product Portfolio Table 72. BASF Recent Development Table 73. Xinzhou Company Information Table 74. Xinzhou Business Overview Table 75. Xinzhou Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Xinzhou Pharmaceutical Grade Omega-3 Product Portfolio Table 77. Xinzhou Recent Development Table 78. TASA Company Information Table 79. TASA Business Overview Table 80. TASA Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. TASA Pharmaceutical Grade Omega-3 Product Portfolio Table 82. TASA Recent Development Table 83. Solutex Company Information Table 84. Solutex Business Overview Table 85. Solutex Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Solutex Pharmaceutical Grade Omega-3 Product Portfolio Table 87. Solutex Recent Development Table 88. Skuny Company Information Table 89. Skuny Business Overview Table 90. Skuny Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Skuny Pharmaceutical Grade Omega-3 Product Portfolio Table 92. Skuny Recent Development Table 93. Sinomega Company Information Table 94. Sinomega Business Overview Table 95. Sinomega Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Sinomega Pharmaceutical Grade Omega-3 Product Portfolio Table 97. Sinomega Recent Development Table 98. Shandong Yuwang Pharmaceutical Company Information Table 99. Shandong Yuwang Pharmaceutical Business Overview Table 100. Shandong Yuwang Pharmaceutical Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Shandong Yuwang Pharmaceutical Pharmaceutical Grade Omega-3 Product Portfolio Table 102. Shandong Yuwang Pharmaceutical Recent Development Table 103. Polaris Company Information Table 104. Polaris Business Overview Table 105. Polaris Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Polaris Pharmaceutical Grade Omega-3 Product Portfolio Table 107. Polaris Recent Development Table 108. Orkla Health Company Information Table 109. Orkla Health Business Overview Table 110. Orkla Health Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Orkla Health Pharmaceutical Grade Omega-3 Product Portfolio Table 112. Orkla Health Recent Development Table 113. Omega Protein Company Information Table 114. Omega Protein Business Overview Table 115. Omega Protein Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Omega Protein Pharmaceutical Grade Omega-3 Product Portfolio Table 117. Omega Protein Recent Development Table 118. OLVEA Fish Oils Company Information Table 119. OLVEA Fish Oils Business Overview Table 120. OLVEA Fish Oils Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. OLVEA Fish Oils Pharmaceutical Grade Omega-3 Product Portfolio Table 122. OLVEA Fish Oils Recent Development Table 123. Nippon Suisan Kaisha Company Information Table 124. Nippon Suisan Kaisha Business Overview Table 125. Nippon Suisan Kaisha Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Nippon Suisan Kaisha Pharmaceutical Grade Omega-3 Product Portfolio Table 127. Nippon Suisan Kaisha Recent Development Table 128. Maruha Nichiro Foods Company Information Table 129. Maruha Nichiro Foods Business Overview Table 130. Maruha Nichiro Foods Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Maruha Nichiro Foods Pharmaceutical Grade Omega-3 Product Portfolio Table 132. Maruha Nichiro Foods Recent Development Table 133. LYSI Company Information Table 134. LYSI Business Overview Table 135. LYSI Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. LYSI Pharmaceutical Grade Omega-3 Product Portfolio Table 137. LYSI Recent Development Table 138. Kinomega Company Information Table 139. Kinomega Business Overview Table 140. Kinomega Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. Kinomega Pharmaceutical Grade Omega-3 Product Portfolio Table 142. Kinomega Recent Development Table 143. KD Pharma (Marine Ingredients) Company Information Table 144. KD Pharma (Marine Ingredients) Business Overview Table 145. KD Pharma (Marine Ingredients) Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 146. KD Pharma (Marine Ingredients) Pharmaceutical Grade Omega-3 Product Portfolio Table 147. KD Pharma (Marine Ingredients) Recent Development Table 148. Hofseth BioCare Company Information Table 149. Hofseth BioCare Business Overview Table 150. Hofseth BioCare Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 151. Hofseth BioCare Pharmaceutical Grade Omega-3 Product Portfolio Table 152. Hofseth BioCare Recent Development Table 153. Golden Omega Company Information Table 154. Golden Omega Business Overview Table 155. Golden Omega Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 156. Golden Omega Pharmaceutical Grade Omega-3 Product Portfolio Table 157. Golden Omega Recent Development Table 158. GC Rieber Company Information Table 159. GC Rieber Business Overview Table 160. GC Rieber Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 161. GC Rieber Pharmaceutical Grade Omega-3 Product Portfolio Table 162. GC Rieber Recent Development Table 163. EPAX Company Information Table 164. EPAX Business Overview Table 165. EPAX Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 166. EPAX Pharmaceutical Grade Omega-3 Product Portfolio Table 167. EPAX Recent Development Table 168. Croda Company Information Table 169. Croda Business Overview Table 170. Croda Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 171. Croda Pharmaceutical Grade Omega-3 Product Portfolio Table 172. Croda Recent Development Table 173. Bioprocess Algae Company Information Table 174. Bioprocess Algae Business Overview Table 175. Bioprocess Algae Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 176. Bioprocess Algae Pharmaceutical Grade Omega-3 Product Portfolio Table 177. Bioprocess Algae Recent Development Table 178. Auqi Company Information Table 179. Auqi Business Overview Table 180. Auqi Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 181. Auqi Pharmaceutical Grade Omega-3 Product Portfolio Table 182. Auqi Recent Development Table 183. Anti-Cancer Company Information Table 184. Anti-Cancer Business Overview Table 185. Anti-Cancer Pharmaceutical Grade Omega-3 Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 186. Anti-Cancer Pharmaceutical Grade Omega-3 Product Portfolio Table 187. Anti-Cancer Recent Development Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Pharmaceutical Grade Omega-3 Distributors List Table 191. Pharmaceutical Grade Omega-3 Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Pharmaceutical Grade Omega-3 Product Image Figure 2. Global Pharmaceutical Grade Omega-3 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade Omega-3 Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceutical Grade Omega-3 Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Pharmaceutical Grade Omega-3 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Marine Omega-3 Image Figure 10. Algae Omega-3 Image Figure 11. Global Pharmaceutical Grade Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Pharmaceutical Grade Omega-3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Type (2021-2032) Figure 14. Global Pharmaceutical Grade Omega-3 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Grade Omega-3 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Grade Omega-3 Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Image Figure 18. Cosmetic Image Figure 19. Global Pharmaceutical Grade Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Pharmaceutical Grade Omega-3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmaceutical Grade Omega-3 Sales Volume Share by Application (2021-2032) Figure 22. Global Pharmaceutical Grade Omega-3 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical Grade Omega-3 Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Pharmaceutical Grade Omega-3 Sales Value Share by Application (2021-2032) Figure 25. Global Pharmaceutical Grade Omega-3 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Pharmaceutical Grade Omega-3 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceutical Grade Omega-3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Pharmaceutical Grade Omega-3 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 30. North America Pharmaceutical Grade Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Grade Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Pharmaceutical Grade Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 36. South America Pharmaceutical Grade Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Pharmaceutical Grade Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Pharmaceutical Grade Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Pharmaceutical Grade Omega-3 Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Pharmaceutical Grade Omega-3 Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Marine Omega-3
  • Algae Omega-3
Applications
  • Pharmaceutical
  • Cosmetic
Companies covered
  • DSM
  • BASF
  • Xinzhou
  • TASA
  • Solutex
  • Skuny
  • Sinomega
  • Shandong Yuwang Pharmaceutical
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • LYSI
  • Kinomega
  • KD Pharma (Marine Ingredients)
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • Croda
  • Bioprocess Algae
  • Auqi
  • Anti-Cancer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade Omega-3 Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade Omega-3 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade Omega-3 Market Dynamics
  1. 2.1 Pharmaceutical Grade Omega-3 Industry Trends
  2. 2.2 Pharmaceutical Grade Omega-3 Industry Drivers
  3. 2.3 Pharmaceutical Grade Omega-3 Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade Omega-3 Industry Restraints
3 Pharmaceutical Grade Omega-3 Market by Company
  1. 3.1 Global Pharmaceutical Grade Omega-3 Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade Omega-3 Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade Omega-3 Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade Omega-3 Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade Omega-3 Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade Omega-3 Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade Omega-3 Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade Omega-3 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade Omega-3 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade Omega-3 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade Omega-3 Market by Type
  1. 4.1 Pharmaceutical Grade Omega-3 Type Introduction
  2. 4.1.1 Marine Omega-3
  3. 4.1.2 Algae Omega-3
  4. 4.2 Global Pharmaceutical Grade Omega-3 Sales Volume by Type
  5. 4.2.1 Global Pharmaceutical Grade Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade Omega-3 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade Omega-3 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade Omega-3 Sales Value by Type
  9. 4.3.1 Global Pharmaceutical Grade Omega-3 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade Omega-3 Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade Omega-3 Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade Omega-3 Market by Application
  1. 5.1 Pharmaceutical Grade Omega-3 Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Cosmetic
  4. 5.2 Global Pharmaceutical Grade Omega-3 Sales Volume by Application
  5. 5.2.1 Global Pharmaceutical Grade Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Grade Omega-3 Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Grade Omega-3 Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pharmaceutical Grade Omega-3 Sales Value by Application
  9. 5.3.1 Global Pharmaceutical Grade Omega-3 Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharmaceutical Grade Omega-3 Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pharmaceutical Grade Omega-3 Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade Omega-3 Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade Omega-3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade Omega-3 Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade Omega-3 Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade Omega-3 Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade Omega-3 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade Omega-3 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade Omega-3 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade Omega-3 Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade Omega-3 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade Omega-3 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade Omega-3 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade Omega-3 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade Omega-3 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade Omega-3 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade Omega-3 Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade Omega-3 Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade Omega-3 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade Omega-3 Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade Omega-3 Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade Omega-3 Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade Omega-3 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade Omega-3 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade Omega-3 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade Omega-3 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade Omega-3 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade Omega-3 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DSM Pharmaceutical Grade Omega-3 Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 BASF
  8. 8.2.1 BASF Company Information
  9. 8.2.2 BASF Business Overview
  10. 8.2.3 BASF Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BASF Pharmaceutical Grade Omega-3 Product Portfolio
  12. 8.2.5 BASF Recent Developments
  13. 8.3 Xinzhou
  14. 8.3.1 Xinzhou Company Information
  15. 8.3.2 Xinzhou Business Overview
  16. 8.3.3 Xinzhou Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xinzhou Pharmaceutical Grade Omega-3 Product Portfolio
  18. 8.3.5 Xinzhou Recent Developments
  19. 8.4 TASA
  20. 8.4.1 TASA Company Information
  21. 8.4.2 TASA Business Overview
  22. 8.4.3 TASA Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TASA Pharmaceutical Grade Omega-3 Product Portfolio
  24. 8.4.5 TASA Recent Developments
  25. 8.5 Solutex
  26. 8.5.1 Solutex Company Information
  27. 8.5.2 Solutex Business Overview
  28. 8.5.3 Solutex Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Solutex Pharmaceutical Grade Omega-3 Product Portfolio
  30. 8.5.5 Solutex Recent Developments
  31. 8.6 Skuny
  32. 8.6.1 Skuny Company Information
  33. 8.6.2 Skuny Business Overview
  34. 8.6.3 Skuny Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Skuny Pharmaceutical Grade Omega-3 Product Portfolio
  36. 8.6.5 Skuny Recent Developments
  37. 8.7 Sinomega
  38. 8.7.1 Sinomega Company Information
  39. 8.7.2 Sinomega Business Overview
  40. 8.7.3 Sinomega Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sinomega Pharmaceutical Grade Omega-3 Product Portfolio
  42. 8.7.5 Sinomega Recent Developments
  43. 8.8 Shandong Yuwang Pharmaceutical
  44. 8.8.1 Shandong Yuwang Pharmaceutical Company Information
  45. 8.8.2 Shandong Yuwang Pharmaceutical Business Overview
  46. 8.8.3 Shandong Yuwang Pharmaceutical Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shandong Yuwang Pharmaceutical Pharmaceutical Grade Omega-3 Product Portfolio
  48. 8.8.5 Shandong Yuwang Pharmaceutical Recent Developments
  49. 8.9 Polaris
  50. 8.9.1 Polaris Company Information
  51. 8.9.2 Polaris Business Overview
  52. 8.9.3 Polaris Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Polaris Pharmaceutical Grade Omega-3 Product Portfolio
  54. 8.9.5 Polaris Recent Developments
  55. 8.10 Orkla Health
  56. 8.10.1 Orkla Health Company Information
  57. 8.10.2 Orkla Health Business Overview
  58. 8.10.3 Orkla Health Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Orkla Health Pharmaceutical Grade Omega-3 Product Portfolio
  60. 8.10.5 Orkla Health Recent Developments
  61. 8.11 Omega Protein
  62. 8.11.1 Omega Protein Company Information
  63. 8.11.2 Omega Protein Business Overview
  64. 8.11.3 Omega Protein Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Omega Protein Pharmaceutical Grade Omega-3 Product Portfolio
  66. 8.11.5 Omega Protein Recent Developments
  67. 8.12 OLVEA Fish Oils
  68. 8.12.1 OLVEA Fish Oils Company Information
  69. 8.12.2 OLVEA Fish Oils Business Overview
  70. 8.12.3 OLVEA Fish Oils Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 OLVEA Fish Oils Pharmaceutical Grade Omega-3 Product Portfolio
  72. 8.12.5 OLVEA Fish Oils Recent Developments
  73. 8.13 Nippon Suisan Kaisha
  74. 8.13.1 Nippon Suisan Kaisha Company Information
  75. 8.13.2 Nippon Suisan Kaisha Business Overview
  76. 8.13.3 Nippon Suisan Kaisha Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Nippon Suisan Kaisha Pharmaceutical Grade Omega-3 Product Portfolio
  78. 8.13.5 Nippon Suisan Kaisha Recent Developments
  79. 8.14 Maruha Nichiro Foods
  80. 8.14.1 Maruha Nichiro Foods Company Information
  81. 8.14.2 Maruha Nichiro Foods Business Overview
  82. 8.14.3 Maruha Nichiro Foods Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Maruha Nichiro Foods Pharmaceutical Grade Omega-3 Product Portfolio
  84. 8.14.5 Maruha Nichiro Foods Recent Developments
  85. 8.15 LYSI
  86. 8.15.1 LYSI Company Information
  87. 8.15.2 LYSI Business Overview
  88. 8.15.3 LYSI Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 LYSI Pharmaceutical Grade Omega-3 Product Portfolio
  90. 8.15.5 LYSI Recent Developments
  91. 8.16 Kinomega
  92. 8.16.1 Kinomega Company Information
  93. 8.16.2 Kinomega Business Overview
  94. 8.16.3 Kinomega Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Kinomega Pharmaceutical Grade Omega-3 Product Portfolio
  96. 8.16.5 Kinomega Recent Developments
  97. 8.17 KD Pharma (Marine Ingredients)
  98. 8.17.1 KD Pharma (Marine Ingredients) Company Information
  99. 8.17.2 KD Pharma (Marine Ingredients) Business Overview
  100. 8.17.3 KD Pharma (Marine Ingredients) Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 KD Pharma (Marine Ingredients) Pharmaceutical Grade Omega-3 Product Portfolio
  102. 8.17.5 KD Pharma (Marine Ingredients) Recent Developments
  103. 8.18 Hofseth BioCare
  104. 8.18.1 Hofseth BioCare Company Information
  105. 8.18.2 Hofseth BioCare Business Overview
  106. 8.18.3 Hofseth BioCare Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Hofseth BioCare Pharmaceutical Grade Omega-3 Product Portfolio
  108. 8.18.5 Hofseth BioCare Recent Developments
  109. 8.19 Golden Omega
  110. 8.19.1 Golden Omega Company Information
  111. 8.19.2 Golden Omega Business Overview
  112. 8.19.3 Golden Omega Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Golden Omega Pharmaceutical Grade Omega-3 Product Portfolio
  114. 8.19.5 Golden Omega Recent Developments
  115. 8.20 GC Rieber
  116. 8.20.1 GC Rieber Company Information
  117. 8.20.2 GC Rieber Business Overview
  118. 8.20.3 GC Rieber Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 GC Rieber Pharmaceutical Grade Omega-3 Product Portfolio
  120. 8.20.5 GC Rieber Recent Developments
  121. 8.21 EPAX
  122. 8.21.1 EPAX Company Information
  123. 8.21.2 EPAX Business Overview
  124. 8.21.3 EPAX Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 EPAX Pharmaceutical Grade Omega-3 Product Portfolio
  126. 8.21.5 EPAX Recent Developments
  127. 8.22 Croda
  128. 8.22.1 Croda Company Information
  129. 8.22.2 Croda Business Overview
  130. 8.22.3 Croda Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Croda Pharmaceutical Grade Omega-3 Product Portfolio
  132. 8.22.5 Croda Recent Developments
  133. 8.23 Bioprocess Algae
  134. 8.23.1 Bioprocess Algae Company Information
  135. 8.23.2 Bioprocess Algae Business Overview
  136. 8.23.3 Bioprocess Algae Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Bioprocess Algae Pharmaceutical Grade Omega-3 Product Portfolio
  138. 8.23.5 Bioprocess Algae Recent Developments
  139. 8.24 Auqi
  140. 8.24.1 Auqi Company Information
  141. 8.24.2 Auqi Business Overview
  142. 8.24.3 Auqi Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Auqi Pharmaceutical Grade Omega-3 Product Portfolio
  144. 8.24.5 Auqi Recent Developments
  145. 8.25 Anti-Cancer
  146. 8.25.1 Anti-Cancer Company Information
  147. 8.25.2 Anti-Cancer Business Overview
  148. 8.25.3 Anti-Cancer Pharmaceutical Grade Omega-3 Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Anti-Cancer Pharmaceutical Grade Omega-3 Product Portfolio
  150. 8.25.5 Anti-Cancer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade Omega-3 Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade Omega-3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade Omega-3 Sales Mode & Process
  6. 9.2 Pharmaceutical Grade Omega-3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade Omega-3 Distributors
  9. 9.2.3 Pharmaceutical Grade Omega-3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst